An activist investor is escalating a campaign against Information Services Corp. and will extend the deadline for a mini-tender offer that seeks to buy as much as 15% of the Canadian database company.

Axsome Therapeutics reports 62% YoY revenue growth in Q1 2025, fueled by Auvelity & Sunosi. Key milestones include Symbravo launch & AXS-14 FDA decision.

At close: May 2 at 4:00:00 PM EDT ...